# Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

> **NCT03004469** · PHASE3 · COMPLETED · sponsor: **Polichem S.A.** · enrollment: 458 (actual)

## Conditions studied

- Alopecia, Androgenetic

## Interventions

- **DRUG:** P-3074
- **DRUG:** Finasteride
- **DRUG:** P-3074 Vehicle
- **DRUG:** Finasteride Placebo

## Key facts

- **NCT ID:** NCT03004469
- **Lead sponsor:** Polichem S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-02
- **Primary completion:** 2018-03-05
- **Final completion:** 2018-03-05
- **Target enrollment:** 458 (ACTUAL)
- **Last updated:** 2019-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03004469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03004469, "Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03004469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*